Company Filing History:

11 out of 2,322

Terumo Kabushiki Kaisha

Tanabe Seiyaku Company, Limited

patents

where one patent can have more than one assignee

Years Active: 1980-1991

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5034414 - Liquid emulsion for transfusion (1991-07-23),

2. 4906631 - Amide derivatives and antiallergic agents containing the same (1990-03-06),

3. 4859673 - Amide derivatives and antiallergic agents containing the same (1989-08-22),

4. 4816486 - Amide derivatives and 5-lypoxygenase inhibitors containing the same (1989-03-28),

5. 4795752 - Amide derivatives and antiallergic agents containing the same (1989-01-03),

6. 4794115 - Method of treating hyperlipemia (1988-12-27),

7. 4792553 - Diene derivatives and vasodilators containing the same (1988-12-20),

8. 4788197 - Pyrazine derivatives useful as platelet aggregation inhibitors (1988-11-29),

9. 4780560 - Nitrate derivatives and vasodilators containing the same (1988-10-25),

10. 4764528 - 2,4-pentadienoic acid derivatives and platelet aggregation inhibitors (1988-08-16),

11. 4704393 - 1-substituted 5-fluorouracil useful for inhibiting the aggregation of (1987-11-03),

12. 4673684 - Amide derivatives and 5-lipoxygenase inhibitors containing the same as (1987-06-16),

13. 4670261 - Parenteral alimentation solution (1987-06-02),

14. 4656172 - 1-[5-(3,4,5-Trimethoxy phenyl)-2,4-pentadienoyl]-4-(substituted (1987-04-07),

15. 4619938 - Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet (1986-10-28),

Title: Innovations of Toshio Wakabayashi

Introduction

Toshio Wakabayashi is a notable inventor based in Tama, Japan. He has made significant contributions to the field of medical technology, holding a total of 17 patents. His work focuses on nutritional solutions and pharmaceutical compounds that have the potential to improve health outcomes.

Latest Patents

Wakabayashi's latest patents include a nutritional liquid emulsion for transfusion. This emulsion comprises a mixture of fatty acid esters containing 20-22 carbon atoms, derived from purified fish oils such as sardine oil, cod oil, squid oil, mackerel oil, or Euphauciacea oil. It also includes purified soybean or safflower oil, purified yolk lecithin or soybean lecithin, and water. This formulation is well-balanced in fatty acid composition, nutritionally valuable, and possesses antithrombotic and anti-arteriosclerotic activities. Another significant patent involves novel amide derivatives that serve as antiallergic agents. Examples of these derivatives include complex chemical structures that demonstrate potential in treating allergic reactions.

Career Highlights

Throughout his career, Wakabayashi has worked with prominent companies in the medical field, including Terumo Kabushiki Kaisha and Terumo Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Wakabayashi has collaborated with notable coworkers such as Makoto Takai and Shin Hattori. Their combined expertise has contributed to the advancement of medical technologies and the development of new therapeutic agents.

Conclusion

Toshio Wakabayashi's contributions to medical innovation through his patents and collaborations highlight his commitment to improving health outcomes. His work continues to influence the field of medical technology and offers promising solutions for various health challenges.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com